(Q35909215)

11 August 2017

Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium (English)

1 reference

11 August 2017

1 reference

5

C G Tropé

1 reference

11 August 2017

M Pradhan

1

1 reference

11 August 2017

V M Abeler

2

1 reference

11 August 2017

H E Danielsen

3

1 reference

11 August 2017

B Sandstad

4

1 reference

11 August 2017

G B Kristensen

6

1 reference

11 August 2017

B Å Risberg

7

1 reference

11 August 2017

30 September 2011

1 reference

11 August 2017

1 reference

11 August 2017

23

1 reference

11 August 2017

5

1 reference

11 August 2017

1178-1184

1 reference

DNA ploidy heterogeneity in endometrial carcinoma: comparison between curettage and hysterectomy specimens

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Prognostic parameters of endometrial carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Prospective Multicenter Validation Confirms the Prognostic Superiority of the Endometrial Carcinoma Prognostic Index in International Federation of Gynecology and Obstetrics Stage 1 and 2 Endometrial Carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Molecular pathogenesis and prognostic factors in endometrial carcinoma

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Endometrial adenocarcinoma in Norway. A study of a total population

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Adenocarcinoma corpus uteri stage I-II: results of a treatment programme based upon cytometry

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Pure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institution.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Prognostic factors in surgical stage I endometrial carcinoma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Significance of morphometric, DNA cytometric features, and other prognostic markers on survival of endometrial cancer patients in northern Norway

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Carcinoma of the endometrium in Norway: a histopathological and prognostic survey of a total population

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Preoperative evaluation of tumor ploidy in endometrial carcinoma: An accurate tool to identify patients at risk for extrauterine disease and recurrence.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3335245

DNA Content Is an Independent Prognostic Indicator in Endometrial Adenocarcinoma A Gynecologic Oncology Group Study

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1093%2FANNONC%2FMDR368

Comparison between flow cytometry and image cytometry in ploidy distribution assessments in gynecologic cancer

21 January 2018

1 reference

12 December 2020

Deoxyribonucleic acid analysis facilitates the pretreatment identification of high-risk endometrial cancer patients

1 reference

12 December 2020

Multivariate analysis of prognostic factors in patients with endometrial cancer

1 reference

12 December 2020

Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications?

1 reference

12 December 2020

Clear cell carcinoma of the endometrium. Prognosis and metastatic pattern

1 reference

12 December 2020

Nuclear DNA content, proliferative activity, and p53 expression related to clinical and histopathologic features in endometrial carcinoma

1 reference

12 December 2020

Frequency of hyperdiploid chromosome complements in endometrioid tumors of the endometrium whereas similar tumors in the ovary tend to show hypodiploidy: a significant difference that may not be distinguishable by flow cytometry of DNA content

1 reference

12 December 2020

Prognostic importance of the nuclear proteins p53 and Rb in conjunction with DNA, nuclear morphometry and grading in endometrial carcinoma

1 reference

12 December 2020

Large-scale genomic instability predicts long-term outcome for women with invasive stage I ovarian cancer

1 reference

12 December 2020

Molecular and histopathologic predictors of distant failure in endometrial cancer

1 reference

12 December 2020

A prospective population-based management program including primary surgery and postoperative risk assessment by means of DNA ploidy and histopathology. Adjuvant radiotherapy is not necessary for the majority of patients with FIGO stage I-II endomet

1 reference

12 December 2020

DNA aneuploidy is associated with increased mortality for stage I endometrial cancer

1 reference

12 December 2020

Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas

1 reference

12 December 2020

The role of DNA ploidy in postoperative management of stage I endometrial cancer

1 reference

12 December 2020

Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting

1 reference

12 December 2020

Identifiers

DOI

10.1093/ANNONC/MDR368

1 reference

11 August 2017

1 reference

11 August 2017

1 reference